Used in research for neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases. Acts as a dual inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), helping to increase acetylcholine levels in the brain, which supports cognitive function. Also inhibits monoamine oxidase B (MAO-B), reducing dopamine breakdown and oxidative stress. This multi-target action makes it a candidate for developing treatments that address both cognitive and motor symptoms in neurodegenerative conditions. Primarily used in preclinical studies to evaluate neuroprotection and symptom improvement.